Cargando…

Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia

It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in patients with febrile neutropenia. We retrospectively examined data relative to 96 patients with hematological malignancies receiving 491 GTs during 114 infectious episodes (IE). Patients were grouped...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teofili, Luciana, Valentini, Caterina Giovanna, Di Blasi, Roberta, Orlando, Nicoletta, Fianchi, Luana, Zini, Gina, Sica, Simona, De Stefano, Valerio, Pagano, Livio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972400/ https://www.ncbi.nlm.nih.gov/pubmed/27487075 http://dx.doi.org/10.1371/journal.pone.0159569

Ejemplares similares

Infectious complications in neonatal transfusion: Narrative review and personal contribution
por: Bianchi, Maria, et al.
Publicado: (2020)

Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
por: Kelly, S, et al.
Publicado: (2009)

Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Update on the management of febrile neutropenia in hematologic patients
por: Escrihuela-Vidal, Francesc, et al.
Publicado: (2019)

Diagnostic Radiology in Hematological Patients with Febrile Neutropenia
por: Heussel, Claus Peter
Publicado: (2014)

Clinical Aspects and Therapy of Sporadic Burkitt Lymphoma
por: Pagano, Livio, et al.
Publicado: (2009)

Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
por: Advani, S. H., et al.
Publicado: (2010)

Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis
por: Orlando, Nicoletta, et al.
Publicado: (2020)

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
por: Demirel, Aslıhan, et al.
Publicado: (2015)

Analysis of hematologic parameters of donors, patients, and granulocyte concentrates to predict successful granulocyte transfusion
por: Lee, Jong-Mi, et al.
Publicado: (2019)

Incidence of Acute Myeloid Leukemia after Breast Cancer
por: Valentini, Caterina Giovanna, et al.
Publicado: (2011)

Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?
por: Aapro, Matti, et al.
Publicado: (2010)

Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies
por: Cugno, Chiara, et al.
Publicado: (2015)

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2014)

Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics
por: Lappalainen, Marika, et al.
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
por: Álvarez, José C., et al.
Publicado: (2021)

The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia
por: Cerasi, Sara, et al.
Publicado: (2023)

Acute Lung Injury Complicating Blood Transfusion in Post-Partum Hemorrhage: Incidence and Risk Factors
por: Teofili, Luciana, et al.
Publicado: (2014)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
por: Cooper, Katy L, et al.
Publicado: (2011)

Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level
por: Baig, Hassam, et al.
Publicado: (2018)

Transfusion-Free Survival Predicts Severe Retinopathy in Preterm Neonates
por: Teofili, Luciana, et al.
Publicado: (2022)

ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients
por: Lakshmaiah, Kuntegowdanahalli C, et al.
Publicado: (2015)

Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
por: Álvarez, José C, et al.
Publicado: (2013)

Corrigendum to “Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update”
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2019)

Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia
por: Korpelainen, Sini, et al.
Publicado: (2017)

Remote Monitoring of Patients With Hematologic Malignancies at High Risk of Febrile Neutropenia: Exploratory Study
por: Kroloff, Maxwell, et al.
Publicado: (2022)

Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor
por: Alshari, Osama, et al.
Publicado: (2021)

Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia
por: Căinap, Călin, et al.
Publicado: (2021)

Effects of primary granulocyte-colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with germ cell tumors
por: Hapakova, Nikola, et al.
Publicado: (2022)

Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
por: Aapro, Matti S., et al.
Publicado: (2023)

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Febrile Neutropenia in Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2018)

Febrile Neutropenia in Children with Cancer
por: Paulus, Stéphane, et al.
Publicado: (2008)

Coronaviruses in children with febrile neutropenia
por: Alvares, Paula A., et al.
Publicado: (2013)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

Granulocyte Antibodies in Korean Neonates with Neutropenia
por: Han, Tae Hee, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_89025ki7vs3kt2447lmmkjmjk7